| RS2135127698 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2135127706 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2135127852 |
EXT2
|
Health Risk |
Likely pathogenic |
Hepatoblastoma, Hepatoblastoma |
| RS2135128105 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2135128191 |
PHF21A
|
Health Risk |
Pathogenic |
— |
| RS2135128814 |
TECTA
|
Health Risk |
Pathogenic |
Bilateral sensorineural hearing impairment, Autosomal dominant nonsyndromic hearing loss 12 |
| RS2135128822 |
TECTA
|
Health Risk |
Likely pathogenic |
— |
| RS2135130818 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS2135141843 |
LTBP3
|
Health Risk |
Pathogenic |
Geleophysic dysplasia 3, Geleophysic dysplasia 3 |
| RS2135143551 |
LTBP3
|
Health Risk |
Likely pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS2135143557 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS2135147324 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2135149193 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder 1, Ataxia-telangiectasia-like disorder 1 |
| RS2135153182 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS2135153244 |
TMEM138
|
Health Risk |
Pathogenic |
Joubert syndrome 16, Joubert syndrome 16 |
| RS2135155640 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS2135157363 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS2135158146 |
TMEM138
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 16, Joubert syndrome 16 |
| RS2135159627 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS2135163033 |
TMEM138
|
Health Risk |
Pathogenic |
Joubert syndrome 16, Joubert syndrome 16 |
| RS2135167716 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2135168243 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group C |
| RS2135177102 |
CABP4
|
Health Risk |
Pathogenic |
— |
| RS2135178682 |
CABP4
|
Health Risk |
Pathogenic |
— |
| RS2135181870 |
CLPB
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2135189980 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2135190077 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2135190154 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2135191306 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome 2 |
| RS2135195989 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2135196385 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2135204843 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2135213081 |
NARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 24, Combined oxidative phosphorylation defect type 24 |
| RS2135221867 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135224893 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135225617 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2135225618 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135227044 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135227381 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135227395 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135227474 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135227564 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135231835 |
KCNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2135232745 |
KCNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2135233808 |
KCNK4
|
Health Risk |
Likely pathogenic |
— |
| RS2135235196 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135236778 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135237416 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2135238203 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135238938 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135239839 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135239944 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135239992 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135241121 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2135241227 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135241404 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2135241864 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135242104 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2135242147 |
TYR
|
Health Risk |
Pathogenic |
— |
| RS2135242551 |
TYR
|
Health Risk |
Likely pathogenic |
— |
| RS2135242595 |
ATM
|
Health Risk |
Likely pathogenic |
Malignant tumor of breast, Familial cancer of breast |
| RS2135242624 |
TYR
|
Health Risk |
Pathogenic |
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN |
| RS2135242925 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135244325 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2135244802 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135244869 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2135245850 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135253045 |
TYR
|
Health Risk |
Pathogenic |
— |
| RS2135253148 |
TYR
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 1A, Oculocutaneous albinism type 1A |
| RS2135253151 |
TYR
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculocutaneous albinism type 1A, Oculocutaneous albinism type 1B |
| RS2135253219 |
TYR
|
Health Risk |
Pathogenic |
— |
| RS2135253360 |
TYR
|
Health Risk |
Pathogenic |
— |
| RS2135253415 |
TYR
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the skin, Oculocutaneous albinism type 1A |
| RS2135256121 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135256420 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135259503 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2135264652 |
SDHD
|
Health Risk |
Pathogenic |
Pheochromocytoma, Cowden syndrome 3 |
| RS2135264840 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135264983 |
ATM
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135265742 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135265770 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135266156 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS2135266498 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135266573 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135266984 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135267332 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2135267333 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cowden syndrome 3 |
| RS2135267337 |
SDHD
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 1, Pheochromocytoma/paraganglioma syndrome 1 |
| RS2135267557 |
SDHD
|
Health Risk |
Pathogenic |
Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss |
| RS2135267768 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2135268427 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2135268548 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135269091 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Paragangliomas with sensorineural hearing loss, Cowden syndrome 3 |
| RS2135269244 |
SDHD
|
Health Risk |
Pathogenic |
Paragangliomas with sensorineural hearing loss, Carney-Stratakis syndrome |
| RS2135269276 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS2135269358 |
SDHD
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 1, Pheochromocytoma/paraganglioma syndrome 1 |
| RS2135269378 |
SDHD
|
Health Risk |
Pathogenic |
Cowden syndrome 3, Pheochromocytoma |
| RS2135269692 |
SDHD
|
Health Risk |
Pathogenic/Likely pathogenic |
Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss |
| RS2135269697 |
SDHD
|
Health Risk |
Pathogenic |
Pheochromocytoma, Cowden syndrome 3 |
| RS2135269732 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |